Shares of, inc. (NYSE:CRM) rose $1.11 during today’s regular trading session, a 1.25% increase from the previous closing price of $88.49. The company’s shares traded on stronger-than-usual volume today: $4.69M shares changed hands while the stock’s average volume is 4.47M shares per day., inc. (CRM) has gained $5.43, or +6.45%, in the last 30 days. This year-to-date, the company’s shares have increased $21.14, or +30.88%. Over the last 12 months, CRM’s stock price has risen $6.85, or +8.28%. The company’s 52-week range is $66.43 to $91.00., inc. (CRM) Earnings Surprises, inc. announced its recent quarter financial results after the market close on 18/05/2017, crushing consensus estimates with both its revenue and earnings., inc. posted net revenue of 2.39B, beating Wall Street analysts who had forecast $2.35B. The company reported EPS of $0.28, above the consensus estimate calling for EPS of $0.26 – a positive surprise of 8.19%.

Before that, quarter ending January 2016,, inc. also surprised analysts by beating the consensus estimate. The Wall Street forecast had projected $0.25 per share, and the company reported EPS of $0.28 – also a 12.31% positive surprise. Revenue during the period amounted to $2.29B, while analysts were anticipating $2.28B.

In the quarter ending October 2016,, inc. delivered smaller earnings beat. Analysts, on average, were expecting $0.21 per share, and the company reported EPS of $0.24 – amounting to a positive surprise of 12.20%. Revenue during that quarter was posted at $2.14B, whereas the consensus estimate was predicting $2.12B.

The company is scheduled to announce its next quarterly financial results on 30/08/2017 after the market close. The average EPS estimate of 5 Wall Street analysts is $0.10 per share, compared to the company’s reported EPS of $0.24 per share in the year-ago quarter. Analysts are forecasting, inc. to report revenue of about $2.51B, versus the $2.04B posted last year., inc. (CRM) Consensus Estimates and Price Target

The company’s consensus rating is currently Strong Buy, with 28 analysts rating it a Strong Buy, and 2 analysts rating it with a Hold. The average 12-month price target, as forecast by analysts, is $97.89, 9.25% higher than the company’s closing price today.